La chaîne d'options affiche les données clés des options sur actions de Conduit Pharmaceuticals à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Conduit Pharmaceuticals..

Conduit Pharmaceuticals (NASDAQ:CDT) Stock, Chaîne d'Options

Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Conduit Pharmaceuticals Inc. - Common Stock

Conduit Pharmaceuticals Inc

Infinitii Ai Inc

CDT Environmental Technology Investment Holdings Limited - ordinary shares

CDT Environmental Technology Investment Holdings Ltd

CDTI ADVANCED MATERIALS by CDTI Advanced Materials, Inc.

CDTi Advanced Materials Inc

Cidara Therapeutics Inc

<a href="https://truthsocial.com/@realDonaldTrump/posts/114813877378281211" title="https://truthsocial.com/@realDonaldTrump/posts/114813877378281211">https://truthsocial.com/@realDonaldTrump/posts/114813877378281211</a>

Macro Economic Events

News

Politics

Economics

General

President Trump Says U.S. Will Impose 36% Tariff On Thailand

Carpenter Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) has outperformed the market over the past 20 years by 3.68% on an annualized basis producing an average annual return of 12.12%. Currently, Carpenter Tech has a market capitalization of $13.97 billion. 
Buying $1000 In CRS: If an investor had bought $1000 of CRS stock 20 years ago, it would be worth $9,784.94 today based on a price of $280.73 for CRS at the time of writing.
<h3>Carpenter Tech's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751921113_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $1000 Invested In Carpenter Tech 20 Years Ago Would Be Worth Today

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Northern Dynasty Minerals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NAK#AMEX">NAK</a>) with a Buy and raises the price target from $1.3 to $2.5.

Price Target

Analyst Ratings

HC Wainwright & Co. Maintains Buy on Northern Dynasty Minerals, Raises Price Target to $2.5

<a href="https://truthsocial.com/@realDonaldTrump/114813871213779514">https://truthsocial.com/@realDonaldTrump/114813871213779514</a>

Macro Notification

President Trump Says U.S. Will Impose 36% Tariff On Cambodia

<a href="https://truthsocial.com/@realDonaldTrump/posts/114813868233643692" title="https://truthsocial.com/@realDonaldTrump/posts/114813868233643692">https://truthsocial.com/@realDonaldTrump/posts/114813868233643692</a>

Government

President Trump Says U.S. Will Impose A 35% Tariff On Serbia

<a href="https://truthsocial.com/@realDonaldTrump/114813866366780377">https://truthsocial.com/@realDonaldTrump/114813866366780377</a>

President Trump Says U.S. Will Impose 35% Tariff On Bangladesh

<a href="https://truthsocial.com/@realDonaldTrump/posts/114813864598173973" title="https://truthsocial.com/@realDonaldTrump/posts/114813864598173973">https://truthsocial.com/@realDonaldTrump/posts/114813864598173973</a>

President Trump Says U.S. Will Impose 32% Tariff On Indonesia

HC Wainwright &amp; Co. analyst Scott Buck maintains Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) with a Neutral and raises the price target from $1.5 to $2.5.

INTZ

HC Wainwright & Co. Maintains Neutral on Intrusion, Raises Price Target to $2.5

<a href="https://truthsocial.com/@realDonaldTrump/posts/114813863196329189">https://truthsocial.com/@realDonaldTrump/posts/114813863196329189</a>

President Trump Says U.S. Will Impose 30% Tariff On Bosnia and Herzegovina

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth assumes Aethlon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) with a Neutral rating and announces Price Target of $1.5.

Initiation

AEMD

HC Wainwright & Co. Assumes Aethlon Medical at Neutral, Announces Price Target of $1.5

PBBK

Trading Halt: Halt status updated at 4:40:00 PM ET: Quotation Resumption: News and Resumption Times

WIIM

APDN

Applied DNA Sciences shares are trading higher after the company announced it regained Nasdaq compliance.

LASE

Laser Photonics shares are trading higher after the company reported a year-over-year increase in Q1 revenue results.

Greenridge Global analyst William Gregozeski initiates coverage on MoneyHero (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNY#NASDAQ">MNY</a>) with a Buy rating and announces Price Target of $4.

Greenridge Global Initiates Coverage On MoneyHero with Buy Rating, Announces Price Target of $4

Global

South Korea Says Will Step Up Trade Negotiations With The US To Win Mutually Beneficial Results And Clear Up Uncertainties Caused By Tariffs

<a href="https://truthsocial.com/@realDonaldTrump/114813842665448662">https://truthsocial.com/@realDonaldTrump/114813842665448662</a>

President Trump Says U.S. Will Impose 25% Tariff On Tunisia

IPOs

ANPA

Rich Sparkle Holdings Limited Announces Pricing Of 1,250,000 Share IPO At $4/Share

A 26-year-old business owner called recently into Dave Ramsey&#8216;s &#8220;<a href="https://www.youtube.com/watch?v=pmwgeIuflGU">EntreLeadership</a>&#8221; podcast with a tough decision: sell the family business for millions or keep building what his father started.
<h2 class="wp-block-heading">Sell Now Or Build Further?</h2>
Dan co-owns a New York-based restaurant cleaning company with his 65-year-old father, who founded the business and is now ready to retire. The company brings in $4.75 million annually and employs 80 cleaners.
After years of working together, a big competitor has offered to buy them out for $6 million. The offer includes $4.5 million in cash and $1.5 million in rollover equity, along with a leadership role for Dan to run the acquiring company's New York City operations.
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation. </a></li>
<li>Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. <a href="https://www.benzinga.com/money/this-company-may-have-found-a-way-to-treat-cancer-by-tricking-the-bodys-immune-system-and-early-studies-show-some-promise-find-out-how-you-can-invest-in-the-future-of-cancer-treatment">Back a bold new approach to cancer treatment with high-growth potential.</a></li>
</ul>
Dan said he and his dad would split the proceeds evenly. &#8220;It&#8217;s more money than either of us have ever seen,&#8221; he admitted.
Ramsey told Dan to think beyond the immediate windfall. &#8220;One of the decision-making formulas I use is I get out of the moment and I extrapolate out decades,&#8221; he said. &#8220;When you&#8217;re 56, and you look back on your life, how are you going to feel about the 26-year-old version of you?&#8221;
Dan said he hadn&#8217;t considered that. &#8220;I never really thought that far out into the future.&#8221; He knows that, <a href="https://www.benzinga.com/money/investing">invested properly</a>, that chunk of change could be worth several million more down the road.
Ramsey agreed the math made sense: &#8220;If you put $2 million in your pocket at 26, it&#8217;s not a bad day.&#8221;
Trending: GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — <a href="https://www.benzinga.com/money/meet-the-company-seeking-to-give-americans-energy-independence-and-learn-how-you-can-become-an-early-investor">Become an Investor in This $41.3M Clean Energy Brand Today</a>
Still, he cautioned against chasing a payout just because it looks good on paper. &#8220;I&#8217;ve known people who got hundreds of millions of dollars for selling their business, and the only thing they got other than that was <a href="https://www.benzinga.com/startups/24/08/40256205/in-2021-charlie-munger-told-warren-buffett-it-was-a-mistake-to-sell-apple-shares-will-he-be-right-ag">wishing they didn&#8217;t sell it</a>,&#8221; he said.
He told the story of a man who sold his company for $400 million but later called it &#8220;the dumbest thing I ever did,&#8221; crying because the company lost its soul under new ownership. &#8220;Selling something for a big chunk of change is not always something that is without regret,&#8221; Ramsey added.
But he didn&#8217;t think Dan would fall into that trap. &#8220;This is an excellent exit for [your dad] and an excellent on-ramp for something else for you,&#8221; he said. &#8220;I think you do this.&#8221;
Still, he left listeners with a straightforward reminder: &#8220;Just because you get a pile of money doesn&#8217;t mean automatically we need to do it.&#8221;
Read Next:
<ul class="wp-block-list">
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
Image: Shutterstock

Personal Finance

Son Wants To Cash Out On Dad's $6 Million Business. Dave Ramsey Brings Up A Teary Man Who Regretted Selling For $400 Million

Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) has outperformed the market over the past 5 years by 304.48% on an annualized basis producing an average annual return of 318.82%. Currently, Quest Diagnostics has a market capitalization of $19.42 billion. 
Buying $1000 In DGX: If an investor had bought $1000 of DGX stock 5 years ago, it would be worth $1,448,542.88 today based on a price of $173.97 for DGX at the time of writing.
<h3>Quest Diagnostics's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751920211_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 85.58% at $1.99</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 44.44% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 25.00% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 12.09% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 11.11% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 10.59% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed up 7.74% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CVSI">CV Sciences</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) shares closed up 7.10% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 5.08% at $0.30</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 4.89% at $0.00</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/AUSAF">Australis Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AUSAF#OTC">AUSAF</a>) shares closed down 99.67% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 16.67% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed down 12.23% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed down 10.65% at $0.22</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 9.71% at $3.45</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 6.53% at $0.50</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Growth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed down 5.48% at $1.20</li>
<li><a href="https://www.benzinga.com/quote/MXC">Mexco Energy</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) shares closed down 5.44% at $8.51</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 5.23% at $6.24</li>
<li><a href="https://www.benzinga.com/quote/RIV">Rivernorth Opps Fund</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIV#NYSE">RIV</a>) shares closed down 4.62% at $12.28</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed down 3.96% at $4.43</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed down 3.74% at $0.01</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

AUSAF

BBRRF

BLGVF

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNBX

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

Comments

Conduit Pharmaceuticals

Conduit Pharmaceuticals (CDT) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL